Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $1.991B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRAX | PRAXIS PRECISION MEDICINES I | 885,500 | $285M | 14.3% | $54.23 | +475.0% | COM NEW | 74006W207 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 17,878,594 | $160M | 8.0% | $11.58 | — | COM NEW | 107924102 |
| EYPT | EYEPOINT INC | 8,265,000 | $107M | 5.4% | $11.03 | +37.9% | COM NEW | 30233G209 |
| EWTX | EDGEWISE THERAPEUTICS INC | 3,260,000 | $103M | 5.2% | $23.73 | +18.8% | COM | 28036F105 |
| ERAS | ERASCA INC | 5,800,000 | $93.84M | 4.7% | $10.02 | 0.0% | COM | 29479A108 |
| RAPP | RAPPORT THERAPEUTICS INC | 2,957,521 | $92.54M | 4.6% | $22.73 | +22.4% | COM | 75383L102 |
| ALMS | ALUMIS INC | 3,949,241 | $87M | 4.4% | $11.79 | +106.2% | COM | 022307102 |
| ABVX | ABIVAX SA | 760,000 | $84.63M | 4.3% | $10.70 | — | SPONSORED ADS | 00370M103 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4,480,433 | $83.52M | 4.2% | $12.11 | +32.6% | CLASS A ORD | 61559X104 |
| DNTH | DIANTHUS THERAPEUTICS INC | 950,000 | $79.72M | 4.0% | $47.58 | 0.0% | COM | 252828108 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 1,059,331 | $77.3M | 3.9% | $35.19 | +138.7% | COM NEW | 10919W405 |
| BBIO | BRIDGEBIO PHARMA INC | 850,000 | $63.12M | 3.2% | $20.96 | +255.4% | COM | 10806X102 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,900,000 | $58.15M | 2.9% | $20.05 | +26.9% | COM | 68062P106 |
| BIOA | BIOAGE LABS INC | 2,890,605 | $50.56M | 2.5% | $19.04 | +0.9% | COM | 09077V100 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,050,000 | $41.71M | 2.1% | $13.13 | — | SPONSORED ADS | 152309100 |
| GLTO | DAMORA THERAPEUTICS INC | 1,525,000 | $39.5M | 2.0% | $25.80 | 0.0% | COM NEW | 36322Q206 |
| MBX | MBX BIOSCIENCES INC | 1,120,000 | $33.43M | 1.7% | $18.80 | +95.9% | COM | 55287L101 |
| INSM | INSMED INC | 190,000 | $31.07M | 1.6% | $37.15 | +328.1% | COM PAR $.01 | 457669307 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 950,000 | $30.41M | 1.5% | $20.31 | +66.2% | ORDINARY SHARES | N62509109 |
| TNGX | TANGO THERAPEUTICS INC | 1,425,000 | $29.81M | 1.5% | $11.91 | 0.0% | COM | 87583X109 |
| PHVS | PHARVARIS N V | 1,000,000 | $28.25M | 1.4% | $21.48 | +24.5% | COM | N69605108 |
| ORKA | ORUKA THERAPEUTICS INC | 533,340 | $26.16M | 1.3% | $14.82 | +118.9% | COM | 687604108 |
| AGMB | AGOMAB THERAPEUTICS NV | 2,465,348 | $25.86M | 1.3% | $10.49 | — | SPONSORED ADS | 00860C102 |
| MAZE | MAZE THERAPEUTICS INC | 750,000 | $22.39M | 1.1% | $44.04 | 0.0% | COM | 578784100 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 2,344,971 | $22.02M | 1.1% | $28.57 | -71.6% | COM NEW | 21833P301 |
| ASND | ASCENDIS PHARMA A/S | 95,000 | $21.73M | 1.1% | $213.24 | — | SPONSORED ADR | 04351P101 |
| ROIV | ROIVANT SCIENCES LTD | 750,000 | $20.77M | 1.0% | $24.17 | 0.0% | SHS | G76279101 |
| ANL | ADLAI NORTYE LTD | 2,897,857 | $20.05M | 1.0% | $6.92 | — | SPONSORED ADS | 00704R109 |
| TERN | TERNS PHARMACEUTICALS INC | 300,000 | $15.82M | 0.8% | $37.46 | 0.0% | COM | 880881107 |
| TARS | TARSUS PHARMACEUTICALS INC | 225,000 | $15.78M | 0.8% | $21.36 | +226.3% | COM | 87650L103 |
| BHVN | BIOHAVEN LTD | 1,760,000 | $14.89M | 0.7% | $11.94 | -1.5% | COM | G1110E107 |
| CABA | CABALETTA BIO INC | 5,500,000 | $14.79M | 0.7% | $1.77 | +47.8% | COM | 12674W109 |
| HLXC | HELIX ACQUISITION CORP III | 1,297,500 | $13.18M | 0.7% | $10.16 | — | USD CL A ORD SHS | G4444S107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 450,000 | $10.6M | 0.5% | $7.71 | +248.2% | COM | 03969K108 |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 306,222 | $9.652M | 0.5% | $13.96 | 0.0% | COM NEW | 81728A207 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 250,000 | $9.08M | 0.5% | $24.75 | +98.8% | COM | 22663K107 |
| ZURA | ZURA BIO LTD | 1,450,000 | $8.627M | 0.4% | $5.88 | 0.0% | CLASS A ORD SHS | G9TY5A101 |
| AXSM | AXSOME THERAPEUTICS INC. | 50,000 | $8.451M | 0.4% | $74.04 | +143.5% | COM | 05464T104 |
| GPCR | STRUCTURE THERAPEUTICS INC | 175,000 | $8.435M | 0.4% | $48.20 | — | SPONSORED ADS | 86366E106 |
| COGT | COGENT BIOSCIENCES INC | 200,000 | $7.698M | 0.4% | $28.11 | +32.9% | COM | 19240Q201 |
| OLMA | OLEMA PHARMACEUTICALS INC | 500,000 | $7.455M | 0.4% | $20.05 | +26.9% | Call | 68062P106 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 400,000 | $6.58M | 0.3% | $20.66 | 0.0% | COM | 61225M102 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 100,000 | $6.27M | 0.3% | $65.73 | 0.0% | COM | 04280A100 |
| PCVX | VAXCYTE INC | 100,000 | $5.811M | 0.3% | $53.56 | -1.5% | COM | 92243G108 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 350,000 | $4.865M | 0.2% | $9.41 | +48.6% | COM | 03237H101 |
| RLYB | RALLYBIO CORP | 400,000 | $3.588M | 0.2% | $5.22 | 0.0% | COM | 75120L209 |
| CNTX | CONTEXT THERAPEUTICS INC | 529,550 | $1.387M | 0.1% | $2.05 | 0.0% | COM | 21077P108 |